Prescribing heroin

American Journal on Addictions

Volumn 14, Issue 4, 2005, Pages 311-318

  Carnwath, Tom ^a,b  

^a Psychological Therapies service   (United Kingdom)

^b West Park Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE;

HEALTH CARE POLICY; HUMAN; MAINTENANCE THERAPY; MEDICAL PRACTICE; NETHERLANDS; OPIATE ADDICTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SWITZERLAND; UNITED KINGDOM;

GREAT BRITAIN; HEALTH POLICY; HEROIN; HUMANS; LICENSURE; NARCOTICS; OPIOID-RELATED DISORDERS; PRESCRIPTIONS, DRUG;

EID: 24944537937     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490591003549     Document Type: Review

References (33)

1. National Treatment Agency. Injectable Heroin (and Injectable Methadone)-Potential Roles in Drug Treatment. London: National Treatment Agency; 2003. Also available at www.nta.nhs.uk
2. House of Commons Home Affairs Committee, Third Report. The Government's Drug Policy: Is It Working? London: HMSO; 2003: paragraph 195.
3. Luty J. New guidelines for prescribing injectable heroin in opiate addiction. Psychiatric Bulletin. 2005;29:123-125.
4. Ministry of Health. Drug Addiction: Report of the Departmental Committee an Morphine and Heroin Addiction. London: HMSO; 1926.
5. Musto DF. The American Disease: Origins of Narcotic Control. New York: Oxford University Press; 1999: 132.
6. Carnwath T, Smith I. Heroin Century. London: Routledge; 2002.
7. Symposium on the proposed legislation banning the legal production of heroin in Great Britain. Br J Addict. 1956;53:39-50.
8. Trebach AS. The Heroin Solution. New Haven, Conn: Yale University Press; 1982.
9. Ministry of Health and Department of Health for Scotland Drug Addiction. Report of the Interdepartmental Committee. London: HMSO; 1961.
10. The Ministry of Health and Scottish Home and Health Department. Drug Addiction: The Second Report of the Interdepartmental Committee. London: HMSO; 1965.
11. Dole V, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. JAMA. 1965;193:80-84.
12. Srimson GV, Metrebian N. Prescribing Heroin. York, UK: Joseph Rowntree Foundation; 2003.
13. Hartnoll RL, Mitcheson MC, Battersby A, et al. Evaluation of heroin maintenance in a controlled trial. Are Gen Psychiatry. 1980;37:877-884.
14. Berridge V, Thom B. The relationship between research and policy: case studies from the postwar history of drugs and alcohol. Contemporary Drug Problems. 1994;21:599-629.
15. Advisory Committee on the Misuse of Drugs. AIDS and Drug Misuse: Update. London: HMSO; 1993.
16. Strang J, Sheridan J. Heroin prescribing in the "British System" of the mid 1990s: data from the 1995 national survey of community pharmacies in England and Wales. Drug and Alcohol Review. 1997;16:7-16.
17. Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ. 1996;313:270-272.
18. Home Office. Tackling Drugs to Build a Better Britain. London: HMSO; 1998.
19. Coid J, Carvell A, Kittler Z, Healey A, Henderson J. The Impact of Methadone Treatment on Drug Misuse and Crime. London: Home Office Research Findings, no. 120; 2000.
20. Metrebian N, Carnwath T, Stimson GV, Storz T. Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction. 2002;97:1155-1161.
21. Zador D. Injectable opiate maintenance in the UK: is it good clinical practice? Addiction. 2001;96:547-553.
22. Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blattler R, Pfeiffer S. Prescription of Narcotics for Heroin Addicts: Main Results of the Swiss National Cohort Study. Basel: Karger; 1999.
23. van den Brink W, Vincent M, Hendriks VM, Blanken P, Huijsman IA, van Ree JN. Medical Co-Prescription of Heroin: Two Randomised Controlled Trials. Utrecht: Central Committee on The Treatment of Heroin Addicts; 2002. Also available at www.ccbh.nl
24. Home Office. Updated Drug Strategy. London: HMSO; 2002.
25. Carnwath T, Merrill J. Dose equivalents in opioid substitution treatment. International Journal of Drug Policy. 2002;13:445-447.
26. McCusker C, Davies M. Prescribing drug of choice to illicit heroin users: the experience of a UK community drug team. J Subst Abuse Treat. 1996;13:521-531.
27. Perneger TV, Giner F, del Rio M, Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ. 1998;317:13-18.
28. Ali R, Auriacombe M, Casas M, et al. Report of the External Panel on the Evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts. Geneva: WHO; 1999.
29. Reed LJ, de Wet C, Bearn J. Prescription of heroin to treatment resistant heroin addicts: replacement therapies need to be tested on a level playing field. BMJ. 2004;328:228.
30. Caplehorn J. Prescription of heroin to treatment resistant heroin addicts: Dutch heroin trials show retention is better with methadone alone. BMJ. 2004;328:228-229.
31. Dehue T. Prescription of heroin to treatment resistant heroin addicts: double blinding is not possible. BMJ. 2004;328:228.
32. van den Brink W, Blanken P, Hendriks VM. Prescription of heroin to treatment resistant heroin addicts: authors' reply. BMJ. 2004; 328:229.
33. Metrebian N, Shanahan W, Stimson GV, et al. Prescribing drug of choice to opiate dependent drug users: a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. Drug and Alcohol Review. 2001;20:267-276.